Paranoid delusions • ideas of reference • sleep problems • Dx?

,; ,; ,

Case Reports

Paranoid delusions • ideas of reference • sleep problems • Dx?

J Fam Pract. 2020 April;69(3):E11-E15

PDF Download

References

1. Howard R, Rabins P, Seeman M, et al. Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international crisis. Am J Psychiatry 2000;157:172-178.

2. Pickard B. Progress in defining the biological causes of schizophrenia. Expert Rev Mol Med. 2011;13:e25.

3. Jeste D, Symonds L, Harris M, et al. Nondementia nonpraecox dementia praecox? Am J Geriatr Psychiatry. 1997;5:302-317.

4. Gourzis P, Katrivanou A, Beratis S. Symptomatology of the initial prodromal phase of schizophrenia. Schizophr Bull. 2002;28:415-429.

5. Dolan R, Fletcher P, Frith C, et al. Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia. Nature. 1995;378:180-182.

6. Skokou M, Katrivanou A, Andriopoulos I, et al. Active and prodromal phase symptomatology of young-onset and late-onset paranoid schizophrenia. Rev Psiquiatr Salud Ment. 2012;5:150-159.

7. Riecher-Rossler A, Loffler W, Munk-Jorgensen P. What do we really know about late-onset schizophrenia? Eur Arch Psychiatry Clin Neurosci. 1997;247:195-208.

8. Lubman D, Castle D. Late-onset schizophrenia: make the right diagnosis when psychosis emerges after age 60. Current Psychiatry. 2002;1:35-44.

9. Howard R, Castle D, Wessely S, et al. A comparative study of 470 cases of early-onset and late-onset schizophrenia. British Journal of Psychiatry. 1993;163:352-357.

10. Harris M, Jeste D. Late-onset schizophrenia: an overview. Schizophr Bull. 1988;14:39-55.

11. Castle D, Murray R. The epidemiology of late-onset schizophrenia. Schizophr Bull. 1993;19:691-700.

12. Lindamer L, Lohr J, Harris M, Jeste D. Gender, estrogen, and schizophrenia. Psychopharmacol Bull. 1997;33:221-228.

13. Gaudiano BA, Dalrymple KL, Zimmerman M. Prevalence and clinical characteristics of psychotic versus non-psychotic major depression in a general psychiatric outpatient clinic. Depress Anxiety. 2009;26:54-64.

14. Saha S, Chant D, Welham J, et al. A systematic review of the prevalence of schizophrenia. PLoS Med. 2005;2:e141.

15. Gao S, Hendrie H, Hall K. The relationships between age, sex, and the incidence of dementia and Alzheimer Disease. JAMA Psychiatry. 1998;55:809-815.

16. Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer Disease. Nature Reviews Neurology. 2011;7:137-152 

17. Winokur G. Delusional Disorder (Paranoia). Comprehensive Psychiatry. 1977;18:511-521.

18. Scheltens P, Leys D, Huglo D, et al. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol, Neurosurg Psychiatry. 1992;55:967-972.

19. Copeland J, Dewey M, Scott A, et al. Schizophrenia and delusional disorder in older age: community prevalence, incidence, comorbidity, and outcome. Schizophr Bull. 1998;24:153-161.

20. Kendler K. Demography of paranoid psychosis (delusional disorder): a review and comparison with schizophrenia and affective illness. Arch Gen Psychiatry 1982;39:890-902.

21. McGrath J, Saha S, Chant D, et al. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008;30:67.

22. Essali A, Ali G. Antipsychotic drug treatment for elderly people with late-onset schizophrenia. Cochrane Database Syst Rev. 2012;(2):CD004162.

23. Sweet R, Pollock B. New atypical antipsychotics- experience and utility in the elderly. Drugs Aging. 1998;12:115-127.

24. Pearlson G, Kreger L, Rabins P, et al. A chart review study of late-onset and early-onset schizophrenia. Am J Psychiatry.1989;146:1568-1574.

The patient tried to leave the ED, saying that her third eye could see the radiation. She required medication and 4-point restraints.

Her initial laboratory work-up for heavy metals, Lyme disease, human immunodeficiency virus (HIV), syphilis, delirium, and drug use were all negative. She also underwent head imaging studies that were also found to be negative. Her mental status exam was notable for a tangential thought process, preservation of delusions with loose associations, labile mood, and dysphoric affect. The patient demonstrated limited insight and judgment, although she was fully oriented to person, place, and time, which suggested against delirium at the time of evaluation.

THE DIAGNOSIS

Based on the patient’s current presentation and in light of her medical history, the health care team arrived at a working diagnosis of late-onset schizophrenia (LOS). The treatment team was able to identify that the current presentation in the ED was the patient’s first episode of psychosis for LOS. The prior 5 to 10 years illustrated a slow progression of odd, yet feasible, chief complaints to multiple clinicians. Reaching the LOS diagnosis sooner had been complicated by the fact that the patient was extremely high functioning in the community.

DISCUSSION

Schizophrenia is a severe, lifelong mental disorder characterized by at least 2 symptoms of delusions, hallucinations, disorganized speech, disorganized or catatonic behavior, or negative symptoms for at least 6 months, with significant social, occupational, and functional deterioration. Current models attribute the neurodevelopmental deregulation of the brain in patients with schizophrenia to dopaminergic hyperactivity and hypofunction of the glutamatergic neurotransmitter system, explaining why its onset is usually in adolescence or young adulthood.^1,2 However, 23% of patients present with symptoms after age 40, with 7% of patients being diagnosed between the ages of 51 and 60.³

Late-onset vs early-onset schizophrenia. LOS is often a missed diagnosis because the clinical presentation is different from early-onset schizophrenia (EOS). Although the prodromal symptoms of EOS and LOS are similar and include marked isolation that subsequently progresses to suspiciousness and ideas of reference,⁴ patients with EOS often also have prodromal negative symptoms. These prodromal negative symptoms associated with EOS may include loss of motivation, social passivity, and disorganized behavior. These symptoms are hypothesized to be caused by dopaminergic dysregulation in the anterior cingulate cortex. EOS is characterized by the patient experiencing more negative symptoms than LOS, which is characterized by the patient experiencing more positive symptoms.

Continue to: Patients with late-onset schizophrenia...